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A B S T R A C T
ARFGEF1 encodes a guanine exchange factor involved in intracellular vesicle traﬃcking, and is a candidate gene
for childhood genetic epilepsies. To model ARFGEF1 haploinsuﬃciency observed in a recent Lennox Gastaut
Syndrome patient, we studied a frameshift mutation (Arfgef1fs) in mice. Arfgef1fs/+ pups exhibit signs of de-
velopmental delay, and Arfgef1fs/+ adults have a signiﬁcantly decreased threshold to induced seizures but do not
experience spontaneous seizures. Histologically, the Arfgef1fs/+ brain exhibits a disruption in the apical lining of
the dentate gyrus and altered spine morphology of deep layer neurons. In primary hippocampal neuron culture,
dendritic surface and synaptic but not total GABAA receptors (GABAAR) are reduced in Arfgef1fs/+ neurons with
an accompanying decrease in the number of GABAAR-containing recycling endosomes in cell body. Arfgef1fs/+
neurons also display diﬀerences in the relative ratio of Arf6+:Rab11+:TrfR+ recycling endosomes. Although the
GABAAR-containing early endosomes in Arfgef1fs/+ neurons are comparable to wildtype, Arfgef1fs/+ neurons
show an increase in the number of GABAAR-containing lysosomes in dendrite and cell body. Together, the
altered endosome composition and decreased neuronal surface GABAAR results suggests a mechanism whereby
impaired neuronal inhibition leads to seizure susceptibility.
1. Introduction
Epileptic encephalopathy (EE) is a group of brain disorders often
with childhood onset and accompanied by serious neurocognitive
consequences (Jain et al., 2013). While linkage and association studies
have suggested that ARFGEF1 is involved in genetic epilepsy (Wallace
et al., 1996; Piro et al., 2011; Addis et al., 2018), it was one of several
candidate genes and no speciﬁc causal ARFGEF1 variants were indicted
previously.
ARFGEF1 encodes Brefeldin A (BFA) inhibited guanine-nucleotide-
exchange protein-1, also known as BIG1 (Addis et al., 2018); and is
highly conserved across mammals and eukaryotes (Wright et al., 2014).
Arfgef1 belongs to the GBF/BIG family based on the relatively large
molecular size compared to other ARF-GEFs and a distinctive feature –
sensitivity to Brefeldin A (BFA) (Yamaji et al., 2000). Among multiple
domains, the BFA-sensitive Sec7 catalytic domain is the most studied
(Le et al., 2013; Lin et al., 2013; Zhou et al., 2013). Arfgef1 selectively
activates Class I ARFs to initiate conversion of ARF-GDP to ARF-GTP
during the process of intracellular vesicle formation and traﬃcking
(Zhao et al., 2002). Earlier studies also showed that the N-terminal DCB
domain interacts with Arl1, targeting Arfgef1 to the trans-Golgi net-
work (TGN) membrane (Galindo et al., 2016); the C-terminus interacts
with kinesin and myosin (Saeki et al., 2005; Shen et al., 2008) as well as
regulating cell surface localization of ABCA1 or GABAAR (Lin et al.,
2013; Li et al., 2014). The role of Arfgef1 in the TGN has been studied in
detail (Manolea et al., 2008; Boal and Stephens, 2010; Lowery et al.,
2013), where it activates Arf1-GTP to recruit clathrin coats, AP1 and
Arf binding proteins, also known as GGAs (Lowery et al., 2013). These
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vesicle-forming components with cargo-sorting capability form new
vesicles and traﬃc cargo from TGN to endosomes or plasma membrane
(Shen et al., 2006).
An earlier study suggested that BIG2 (Arfgef2) is functionally as-
sociated with endosomal integrity whereas Arfgef1 is associated with
the Golgi (Shen et al., 2006). However, newer evidence suggests that
Arfgef1 is also localized on endosomes (D'Souza et al., 2014). Since the
main Arfgef1 target, Arf1, localizes on recycling endosomes and reg-
ulates traﬃcking from recycling endosome to plasma membrane (Nakai
et al., 2013) and GGAs are known to facilitate traﬃcking between TGN
and lysosomes (Hirst et al., 2000), it is reasonable to suggest that
Arfgef1 may have a role in post-TGN endosomal traﬃcking, similar to
that of BIG2. However, this aspect of Arfgef1 is understudied.
Arfgef1 regulates neurite development in vitro (Zhou et al., 2013).
Recently, diﬀerent groups demonstrated that Arfgef1 is required both
for the survival of cortical deep layer neurons and for the initiation of
neuronal myelination (Teoh et al., 2017; Miyamoto et al., 2018). An-
other in vitro study showed that decreased Arfgef1 abundance is cou-
pled with decrease of plasma membrane GABAAR without aﬀecting
total GABAAR, resulting in impaired chloride ion inﬂux (Li et al., 2014).
However, it is not yet known directly whether Arfgef1 has a role in
phenotypes that rely on maintaining inhibition:excitation balance in
vivo.
Understanding the underlying disease etiology and mechanisms
may provide insight for new therapies, especially needed for severe
childhood epilepsies. Here, we examine the eﬀect of Arfgef1 hap-
loinsuﬃciency in a new mouse line based on a Lennox-Gastaut patient
that carries a de novo loss of function mutation in ARFGEF1.
2. Results
2.1. ARFGEF1 de novo nonsense mutation in a Lennox-Gastaut Syndrome
patient
ARFGEF1 was detected as a candidate gene in a boy diagnosed with
Lennox-Gastaut Syndrome. Seizures began at 6months of age, and were
subsequently diagnosed as infantile spasms. By 3 years of age, the pa-
tient exhibited generalized convulsions as well as myoclonic, tonic, and
atonic seizures. Neurological exams showed global developmental
delay and axial hypotonia. He had no language and no meaningful
vocalizations. He was unable to pull to stand or support his own weight.
General physical exam results were normal and no dysmorphic features
was observed. The electroencephalogram (EEG) initially showed hyp-
sarrhythmia and infantile spasms. Subsequent EEGs showed the emer-
gence of generalized slow spike-and-wave activity along with parox-
ysmal fast activity and persistence of multifocal epileptiform
discharges, superimposed on a high amplitude, disorganized back-
ground. He was treated initially with ACTH, followed by multiple
medications including vigabatrin, levetiracetam, clonazepam, zonisa-
mide, phenobarbital, lamotrigine, valproic acid, and ruﬁnamide. He
was also treated with the ketogenic diet and underwent a corpus cal-
losotomy. Despite these interventions the seizures remained severely
refractory.
Exome sequencing performed as part of the Epi4k Collaborative
(Epi4K Consortium et al., 2013) revealed a single nucleotide variant
resulting in a premature translational stop codon in exon 30 of the
ARFGEF1 gene (ENST00000262215.3:c.4365C>A; p.Cys1455Ter).
The patient also has a missense mutation in the BMP2 gene
(ENST00000378827.4:c.328C>A; p.Arg110Ser), classiﬁed as “prob-
ably damaging” based on a PolyPhen-2 score of 0.968. However, since
BMP2 variants have not yet been associated with neurological disease
in human or mouse, and because Arfgef1 null mouse mutants have
abnormal brain development (Teoh et al., 2017), we considered
ARFGEF1 the more likely candidate.
2.2. Genetic analysis of Arfgef1 haploinsuﬃciency
We generated an Arfgef1 knockout mouse line on the C57BL/6NJ
strain background by using CRISPR/Cas9 to target the orthologous re-
gion on mouse Chromosome 1 (Fig. 1A; Methods). Line Arfgef1em3Frk
(shown hereafter as Arfgef1fs) has a 4-nt frameshift mutation in exon 30,
resulting in a premature termination codon (MQYVMYSPSI*) closely
mimicking the patient's mutation. Although heterozygous mice are vi-
able and fertile, all homozygotes died within one day of birth, similar to
a previous report of the Arfgef1 knockout mouse (Teoh et al., 2017).
The presence of cDNA and protein in whole brain at embryonic day
17.5 was examined using primer pairs ﬂanking N-terminal DCB do-
main, Sec7 domain, exon 29–31 (mutation in exon 30) and C-terminal
HDS4 domain (Fig. S1). The Arfgef1 protein was not detected in Arf-
gef1fs/fs whole brain lysate using Arfgef1 antibodies with N-terminal
epitopes (Fig. 1B). In Arfgef1fs/+ brain, Arfgef1 protein was lower in
abundance than wildtype, consistent with haploinsuﬃciency. The brain
size of E17.5 embryos from Arfgef1fs/+ were comparable to wildtype
except that the Arfgef1fs/fs forebrain was notably smaller.
2.3. Developmental delay in Arfgef1fs/+ mouse pups
We studied the impact of the Arfgef1fs/+ genotype in mouse pups, to
explore parallels with the Lennox-Gastaut Syndrome patient. Newborn
pups are known to perform typical behavioral activities that serve as
benchmarks for neurodevelopmental delay during postnatal develop-
ment (Hill et al., 2008). Arfgef1fs/+ pup body weight did not change
signiﬁcantly from postnatal day (PND) 3 to PND11 (Fig. 2A), suggesting
that the feeding behavior was normal. However, in the ﬁrst week sev-
eral milestones showed modest deﬁcit, including latencies to surface
righting reﬂex and negative geotaxis (Fig. 2B, C), while vertical screen
holding was similar to wildtype (Fig. 2D, E). Pups younger than PND12
emit ultrasonic vocalization (USV) when separated from dam and lit-
termates (Ferhat et al., 2016). The USV calls in wildtype pups peaked at
PND6 and then gradually diminished. In contrast, the peak incidence
and diminishment of USV calls was signiﬁcantly delayed in Arfgef1fs/+
(Fig. 2F), suggestive of developmental delay. Representative samples of
USV calls from wildtype and Arfgef1fs/+ pups are shown in Fig.S2.
2.4. Morphological defects in Arfgef1fs/+ brains and neurons
An earlier study showed that the Arfgef1 knockout heterozygotes
have normal brain size during embryogenesis (Teoh et al., 2017), but
the postnatal brain was not examined. First, we observed that Arfgef1fs/
+ mice showed transient weight loss by PND14, and catch-up to
wildtype by PND45 (Fig. 3A). Using this as a guide for histological
examination, we then compared Arfgef1fs/+ and wildtype brain at
PND14, PND30 and PND45 (Fig. 3B). The overall brain size of Arfgef1fs/
+ was similar to wildtype, but dysregulated growth in the dentate gyrus
lining of Arfgef1fs/+ hippocampus was apparent from PND30 (Fig. 3B,
red arrowheads). We then examined the morphology of single neuron
by diolistic labeling using DiI, a lipophilic dye that diﬀuses through the
membrane lipid bilayer and stains the whole cell structure, ﬁrst in
primary neuron culture and then in brain slices. At 14 days in vitro
(DIV), we observed long, ﬁlamentous and tertiary branch-like struc-
tures with larger growth cones on the dendrite of Arfgef1fs/+ primary
hippocampal neurons (Fig. 3C, red arrowheads). These tertiary struc-
tures did not adhere to the culture dish surface compared to the re-
spective primary dendrite. Larger growth cone size has been shown to
correlate with slower neurite growth rate (Ren and Suter, 2016), sug-
gesting a delay in dendritic branch maturation. In Arfgef1fs/+ brain
slices, although the total number of dendritic spines (per unit length)
was similar in deep layer neurons of both genotypes (Fig. 3D, E), the
distribution of spine morphological subtypes was altered. In Arfgef1fs/+
dendrites, the fraction of mushroom-shaped spines was signiﬁcantly
higher than observed in wildtype (Fig. 3D, bottom inset, red
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arrowheads), whereas there were fewer thin spines and ﬁlopodia
(Fig. 3F). Since mushroom spines on cortical deep layer neurons are
typically more persistent than the immature thin spines or ﬁlopodia
(Trachtenberg et al., 2002), this evidence suggested changes in den-
dritic spine plasticity.
2.5. Seizure susceptibility of Arfgef1fs/+ adult mice
In four years of breeding, Arfgef1fs/+ mice show no signs of spon-
taneous convulsive seizure throughout their lifetime, nor was there
evidence of seizure or epileptiform activity in 48 h video-EEG record-
ings of heterozygous adult mice (Fig. S3). However, both male and
female heterozygotes have a signiﬁcantly reduced electroconvulsive
threshold to the minimal forebrain clonic seizure endpoint, compared
with wildtype littermates (Wilcoxon test with permutation p=0.003
and p=0.001, respectively; Fig. 4A). They are also susceptible to tonic-
clonic seizures induced by subcutaneous GABAAR antagonist pentyle-
netetrazol (PTZ) at a dose (40mg/kg) near the threshold for wildtype
C57BL/6NJ mice. Thus, 92.7% of Arfgef1fs/+ heterozygotes reached the
tonic-clonic seizure or worse endpoint, in contrast to 18.2% of wildtype
mice (p < 0.0001, Fisher's Exact Test). The average latency to the ﬁrst
tonic-clonic seizure was also signiﬁcantly shorter in Arfgef1fs/+ mice,
by an average of 788 s (Wilcoxon test with permutation p < 0.001;
Fig. 4B).
2.6. Decreased dendritic surface GABAAR in Arfgef1fs/+ neurons
Li et al. (2014) previously demonstrated that siRNA-mediated de-
pletion of Arfgef1 could reduce functional GABAAR at the membrane
surface (Li et al., 2014). Given the morphological features and seizure
susceptibility of Arfgef1fs/+ mice, we examined GABAAR localization in
primary hippocampal neuron culture. Through immunoﬂuorescence
staining of permeabilized neurons, we determined that the total number
of GABAAR puncta in the Arfgef1fs/+ proximal dendrite was similar to
that of wildtype (Fig. 5A, D). However, on non-permeabilized neurons,
dendritic surface-bound GABAAR puncta count decreased in Arfgef1fs/+
(Fig. 5B, E). GABAAR puncta colocalized with synaptophysin, a synaptic
marker, also decreased (Fig. 5C, F), together suggesting a decrease in
synaptic GABAAR density along the dendritic surface. Initial assessment
of synaptic properties of hippocampal pyramidal neurons from these
cultures at DIV14 showed that Arfgef1fs/+ neurons had a nominal in-
crease in mean mEPSC frequency and no diﬀerence in mIPSC frequency
or in mEPSC or mIPSC amplitude (Fig. S4A, B, C).
Fig. 1. Generation and genotyping of Arfgef1fs mice. A, CRISPR/Cas9 targeting Arfgef1 exon 30 on mouse Chromosome 1 resulted in a 4-nt frameshift mutation
(Arfgef1fs). The heterozygotes (Arfgef1fs/+) were veriﬁed with Sanger sequencing. The red box shows the sites of mutation for Arfgef1fs correspond to HDS3 domain in
Arfgef1 protein. B, Western blot was performed using E17.5 brain lysate (n= 3 animals per genotype) and detected using antibody targeting Arfgef1 based on an N-
terminal epitope, with ß-tubulin as loading control. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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2.7. Disrupted distribution of GABAAR-containing traﬃcking vesicles in
Arfgef1fs/+ neurons
Because the total GABAAR puncta count remained unchanged, we
reasoned that the decrease in synaptic GABAAR may result from mal-
function either in receptor traﬃcking or in recycling to the plasma
membrane. That is, GABAAR might either be endocytosed but cannot be
recycled to the plasma membrane (Li et al., 2014), or there is slowdown
in traﬃcking of GABAAR from Golgi to plasma membrane.
There is signiﬁcant heterogeneity in the type and subcellular loca-
lization of recycling endosomes in neurons, and this heterogeneity is in
part represented by Arf6+, Rab11+, TrfR+ markers. For example,
Arf6+ but not Rab11+ and TrfR+ recycling endosomes respond to
nerve growth factor (NGF) stimulation, suggesting functional diﬀer-
ences in recycling endosome species (Kobayashi and Fukuda, 2013).
Immunoﬂuorescent staining of primary hippocampal neurons showed
that Arf6+, Rab11+ and Trf+ puncta colocalized with GABAAR+
puncta in dendrite and cell body (Fig. S5A, B, C). Vesicle-GABAAR co-
localization was quantiﬁed using object-based colocalization (see
Methods). We found that the number of Arf6+, Rab11+ and Trf+ ve-
sicles each decreased in the Arfgef1fs/+ neuronal cell body (Fig. S6Ai,
Bi, Ci), as were those that colocalized with GABAAR (Fig. 6Ai, Bi, Ci).
These results suggest either an increase in the dendritic GABAAR re-
cycling, leading to reduction in retrograde traﬃcking into the cell body,
or increase in the recycling endosome that mature into late endosomes.
The former is less likely because we observed less dendritic surface-
bound GABAAR. Findings in dendrites further reinforced this idea: in
Arfgef1fs/+ dendrites, Arf6+ recycling endosomes decreased in number
compared to wildtype (Fig. S6Aii), including those that colocalized with
GABAAR (Fig. 6Aii). In contrast, the number of Rab11+ and TrfR+
recycling endosomes (Fig. S6Bii, Cii) including those colocalized with
GABAAR (Fig. 6Bii, Cii) in Arfgef1fs/+ dendrite were comparable to
wildtype. These results suggest that Arfgef1 haploinsuﬃciency not only
reduces the number of Arf6+, Rab11+, TrfR+ recycling endosomes in
cell body, but also speciﬁcally aﬀects Arf6-dependent dendritic GA-
BAAR recycling.
It is useful to consider the impact of Arfgef1 genotype on the relative
ratio of Arf6+, Rab11+, and TrfR+ recycling endosomes, because of the
interelationship between these microorganelles. Pairwise comparisons
of mutant to wildtype showed that the recycling endosome ratio was
signiﬁcantly skewed in Arfgef1fs/+ dendrite (p=0.006) but not in cell
body (p=0.252). The imbalance in recycling endosome populations in
Fig. 2. Developmental milestone and ultrasonic vocalization of Arfgef1fs/+ pups. A, There was no diﬀerence in body weight of Arfgef1fs/+ and wildtype pups from
PND3 to PND11. B, C, The latency to surface righting or negative geotaxis (90° turn) of Arfgef1fs/+ pups is longer than wildtype at PND5. D, E, There is no diﬀerence
in latency between genotypes in negative geotaxis (180° turn) or vertical screen holding. F, The incidence of maternal separation-associated ultrasonic vocalizations
is higher at PND8 and PND10 for Arfgef1fs/+ compared to wildtype. Data were collected from pups of both sexes; wildtype, n=22 animals; Arfgef1fs/+, n= 23
animals from 7 litters. Permutation p-values shown were determined using the Wilcoxon rank-sum test.
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dendrite could be the reason for the decrease of dendritic surface
GABAAR.
The early endosome is an intermediate organelle, which can either
turn into recycling endosomes or mature into lysosomes (Naslavsky and
Caplan, 2018). Earlier evidence showed that Arfgef1 also localizes on
early endosomes and functions similarly as Arfgef1 localizes in the
trans-Golgi network (D'Souza et al., 2014). Reduction in the number of
early endosomes in the Arfgef1fs/+ dendrite could explain the decrease
in recycling endosomes. Immunoﬂuorescent staining of primary hip-
pocampal neurons showed that EEA1+ puncta colocalized with GA-
BAAR+ puncta in cell body and dendrite (Fig. S5D). However, when
compared to wildtype, there were no changes in the number of EEA1+
early endosomes in dendrite or cell body of Arfgef1fs/+ neurons (Fig.
S6Di, ii), or those that colocalize with GABAAR (Fig. 6Di, ii).
Multiple studies in non-neuronal cells demonstrated that Arfgef2
but not Arfgef1 colocalizes with Arf6+, Rab11+, TrfR+ or EEA1+ en-
dosomes (Togawa et al., 1999; Shin et al., 2004; Ishizaki et al., 2008;
D'Souza et al., 2014). In DIV 14 primary hippocampal neurons, we
found that both Arfgef1 (Fig. S7A, B, C, D) and Arfgef2 (Fig. S7E, F, G,
H) puncta overlapped with Arf6+, Rab11+, TrfR+ or EEA1+ puncta.
The number of Arfgef1+ puncta colocalized with Arf6+, Rab11+,
TrfR+ or EEA1+ puncta were not diﬀerent between Arfgef1 genotypes
(Fig. 6F). However, the number of Arfgef2+ puncta that colocalized
with Arf6+, but not Rab11+, TrfR+ and EEA1+, is signiﬁcantly lower
than wt in Arfgef1fs/+ dendrites (Fig. 6G). This suggests that Arfgef2
might compensate for the reduction of Arfgef1 at Golgi in the cell body.
2.8. Accumulation of GABAAR in lysosomes in Arfgef1fs/+ neurons
The decrease of surface GABAAR accompanied by decrease in re-
cycling endosomes suggest that the internalized receptors might have
been targeted elsewhere. It has been shown that internalized GABAAR
that fail to recycle to the plasma membrane are directed to lysosomes
for degradation (Kittler et al., 2004). This led us to ascertain whether
reduction in surface GABAAR was accompanied by lysosomal accumu-
lation of GABAAR. Indeed, in cell body and dendrite of Arfgef1fs/+
neurons, Lamp1+ lysosome number (Fig. S6Ei,ii), and those colocalized
with GABAAR (Fig. 6Ei, ii, H) increased compared to wildtype. This
Fig. 3. Morphological characterization of Arfgef1fs/+ mice. A, Body weight of Arfgef1fs/+ mice is lower at PND14 and PND30 compared to wildtype mice. E17.5,
wildtype, n=16; Arfgef1fs/+, n=12 from 4 litters; PND14, 30 and 45, wildtype, n= 7 mice; Arfgef1fs/+, n=8 mice from 5 litters. B, H&E-stained sagittal sections
shows irregular bumps (red arrowheads) along Arfgef1fs/+ dentate gyrus lining (red dotted lines) at PND30 and PND45. n= 3 animals per genotype for each time-
point. Scale bars, sagittal sections, 500 μm; HIP, 500 μm; DG, 100 μm. C, In DIV14 primary hippocampal neuron culture, ﬁlamentous tertiary structures with large
growth cones (red arrowheads) appeared on Arfgef1fs/+ neurons; wildtype: 4 neurons from 1 animal; Arfgef1fs/+, n= 11 neurons from 3 animals. Scale bars, 50 μm;
inset, 10 μm. D, Single deep layer neuron labeled using diolistic method in PND14 deep layer neurons. Mushroom spines are marked by red arrowheads. E & F, The
total spine density is similar between Arfgef1fs/+ neurons and wildtype neurons. However, spine subtype density (mushroom, thin and ﬁlament) are signiﬁcantly
diﬀerent; n= 3 animals each genotype. Scale bars, 20 μm; enlarged box, 10 μm. Data were collected from mice of both sexes. HIP, hippocampus; DG, dentate gyrus.
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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showed that GABAAR in Arfgef1fs/+ neurons were redirected to lyso-
somes instead of being recycled to the plasma membrane.
3. Discussion
Arfgef1fs/+ mice were generated to model a Lennox-Gastaut
Syndrome patient heterozygous for a de novo mutation that creates a
premature translational stop in the Arfgef1 C-terminus, and thus a
haploinsuﬃcient state via presumed nonsense-mediated decay.
Arfgef1fs/+ mice do not have spontaneous convulsions, as is sometimes
the case with genotypically accurate mouse models of childhood epi-
lepsy that either do not have spontaneous seizures (Frankel et al., 2009;
Amendola et al., 2014) or have seizures of a diﬀerent type than de-
scribed in the respective patients (Warner et al., 2016; Kovacevic et al.,
2018). However, Arfgef1fs/+ do have a low threshold to induced sei-
zures, indicating clear seizure susceptibility. Their abnormal perfor-
mance in developmental milestone tasks, modest but signiﬁcant, also
suggests global developmental delay and possibly hypotonia, like the
patient. The predicted maturation rate for mouse is 150 times faster
than human in the ﬁrst month. Thus, the age at which the Arfgef1fs/+
developmental features are most apparent, between ages PND5 and
PND7, is equivalent to a 2–3 year child (Flurkey et al., 2007). This very
rapid postnatal maturation in mouse may also partly account for
compensatory neurodevelopmental features that prevent a more severe
outcome, such as spontaneous seizures.
Arfgef1fs/+ animals have a normal lifespan, whereas Arfgef1fs/fs die
perinatally; in agreement with the earlier report of Arfgef1 knockout
mice (Teoh et al., 2017), except the forebrain defect evident at E17.5 in
Arfgef1fs/fs mice, is more severe. This diﬀerence could be due merely to
genetic background: the earlier study did not use an inbred strain but
rather a mixed 129/SvJ;C57BL/6J background in which hybrid vigor
may have mitigated severity.
The GABAAR is a membrane-bound ligand-gated ion channel se-
lective for chloride ions (Moroni et al., 2011). Accumulation of GABAAR
at the synaptic site is required for inhibitory synapse formation and for
fast synaptic inhibition (Bogdanov et al., 2006). Other than being
traﬃcked from Golgi to plasma membrane (Luscher et al., 2011), sur-
face GABAA receptors also undergo constitutive endocytosis and then
are recycled back to the membrane surface or delivered to lysosome for
degradation (Kittler et al., 2000). Our results suggest that both copies of
Arfgef1 are required to maintain normal endosome composition, which
is in turn critical for receptor recycling.
Arl1 recruits Arfgef1 to early endosomes (D'Souza et al., 2014).
Internalized membrane surface receptors fed into early endosomes have
several fates. Surface receptors stay in early endosomes if they are not
quickly recycled to plasma membrane from early endosomes or deliv-
ered into recycling endosomes for slow recycling. The early endosomes
with surface receptors that are not destinied for recycling then mature
into lysosomes for degradation (Kittler et al., 2004; Naslavsky and
Caplan, 2018). In Arfgef1fs/+ neurons, there was no change in dendritic
early endosome number but Arf6+ recycling endosomes were available
albeit fewer in number, suggesting that less early endosomes are des-
tined for recycling – as supported by our observation of decreased
GABAAR on the Arfgef1fs/+dendrite surface; these vesicles mature into
lysosomes, which are more abundant in the Arfgef1fs/+ cell body.
The imbalance of recycling and early endosome populations may
also explain why there are more lysosomes in Arfgef1fs/+. AP1 and
GGAs, recruited by the Arfgef to the trans-Golgi network, are required
to regulate lysosomal enzyme traﬃcking from the trans-Golgi to lyso-
somes (Le Borgne and Hoﬂack, 1998; Hirst et al., 2000; Lowery et al.,
2013). Depletion of Arfgef1 alone does not aﬀect the level of GGAs in
the trans-Golgi network (Boal and Stephens, 2010; Miyamoto et al.,
2018). It has also been demonstrated that the number of synaptic GA-
BAARs increase in GGA-deﬁcient mice (Walker et al., 2016). However,
depletion of Arfgef1 reduces the formation of AP-1 complex. Notably,
such depletion does not entirely eliminate AP-1 (Miyamoto et al.,
2018). Since Arfgef2 can compensate for Arfgef1 in the trans-Golgi
network (Ramaen et al., 2007), AP-1 and GGAs levels are required for
maintaining the network through to lysosomal traﬃcking, thus the
degradation rate would be be maintained in Arfgef1fs/+ neurons. In our
study, although there is signiﬁcantly less dendritic surface-bound GA-
BAAR, some GABAAR can still be transported to the membrane surface.
Thus, the reduction of surface GABAAR is most likely due to reduced
recycling, leading to increased GABAAR accumulation in lysosomes.
We can only speculate why Arfgef1 haploinsuﬃciency in mouse is
less severe than the human disease it models, or why more ARFGEF1
variants have not been found in epilepsy. Lennox-Gastaut Syndrome is a
genetically heterogeneous complex childhood epilepsy, if a primary
gene is known at all. Arfgef1 homozygous knockouts are very severely
impaired. One possibility is that a very delicate balance of gene dosage,
combined with a limited window of late gestational or early postnatal
vulnerability, allows the more rapid mouse postnatal development to
push through. A more discrete possibility is that ARFGEF1 is actually a
modiﬁer mutation, requiring another predisposing variant for severe
disease. In multiple prior studies, ARFGEF1 was reported as a candidate
together with at least one other gene. For example, in a large Australian
family spanning three generations in which CRH had been proposed as
a EE candidate gene (Wallace et al., 1996), Piro and colleagues later
suggested that ARFGEF1 was also plausible (Piro et al., 2011). In an-
other study of copy number variants (CNV), the authors reported an EE
patient with onset of 10 years with ARFGEF1 and CSPP1 as candidate
genes (Addis et al., 2018). In our study, the Lennox-Gastaut patient also
carried a nonsynonymous BMP2 variant; while BMP2 is not yet asso-
ciated with epilepsy at least one study has shown that BMP2 signaling
promotes the diﬀerentiation of some GABAergic neurons (Yao et al.,
2010). Regardless, the speciﬁc impact of Arfgef1 haploinsuﬃciency on
endosomal balance and dendritic vesicle fate is an attractive pathogenic
mechanism and therapeutic target opportunity that may apply to other
forms of childhood epilepsy.
4. Materials and methods
4.1. Generation of Arfgef1 mice
All mice breeding and husbandry were done within the Institute of
Comparative Medicine in Columbia University. The mice were kept
under a 12-h day-night cycle with unlimited access to water and food.
Mice at two to six-months-old were used for mating. All animal-related
procedures were performed according to the guidelines of the
Fig. 4. Seizure susceptibility of Arfgef1fs/+ mice. A, Electroconvulsive threshold
to the minimal clonic seizure endpoint is signiﬁcantly lower in Arfgef1fs/+ mice
of both sexes (male, wildtype, n= 11; Arfgef1fs/+, n=18; female, wildtype,
n= 11; Arfgef1fs/+, n=15). B, The latency to PTZ-induced tonic-clonic seizure
is signiﬁcantly shorter for Arfgef1fs/+ mice; wildtype, n= 4; Arfgef1fs/+,
n= 11. Permutation p-values shown were determined using the Wilcoxon rank-
sum test.
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Institutional Animal Care and Use Committee (IACUC) of Columbia
University. The germline mutation mice were generated in the Genetic
Engineering and Technology Core at The Jackson Laboratory (Bar
Harbor, ME). In mouse, the Arfgef1 gene is on Chromosome 1 and
consists of 38 exons. Brieﬂy, a guide RNA directing Cas9 endonuclease
together with a single-stranded repair template targeting exon 30 was
injected into single-cell mouse embryos of C57BL/6NJ line. Founder
line were genotyped using PCR (primer F3, 5′-GTCTGAAGTGAAGCAC
GTTGG-3′ and primer R3, 5′-CAGTGGGGTCAACGTGTTATG-3′), re-
striction enzyme digestion (MwoI; New England Biolabs, R0573L) and
DNA sequencing (primer F2, 5’-GTGGCTAGAGAGGCTCGTTTT-3′).
Identiﬁed founder mice were crossed with wildtype C57BL/6NJ, re-
sulting Arfgef1fs line (4-nt deletion in exon 30).
4.2. RT-PCR
Total RNA was collected from wildtype and Arfgef1fs/+ brains at
embryonic day 17.5 (E17.5) using TRIzol reagent (Ambion, 15596026).
Reverse transcription was performed using SuperScript™ III First-Strand
Synthesis SuperMix for qRT-PCR (Invitrogen, 11752-050) according to
the manufacturer's protocol. PCR was then performed using primers
ﬂanking Arfgef1 cDNA corresponding to the exons 3–6 (N-terminal DCB
domain), exons 13–17 (Sec7 domain), exons 29–31 (mutation site) and
exons 31–38 (C-terminal HDS4 domain) with primerd ﬂaking actin as
control. The PCR products were subjected to electrophoresis on 2%
agarose gels. The primers used in this experiment were listed below.
DCB domain
Forward: 5′- CAC CCT TCC ACC AGT GAA ATC A -3′.
Reverse: 5′- TGC TGC CGA TGT CTT TCT CTT TC -3′.
Fig. 5. Membrane surface GABAAR and synaptic GABAAR distribution in Arfgef1fs/+ neurons. A, There is no diﬀerence in the localization of total GABAAR puncta in
proximal dendrite. B, GABAAR localize on dendritic surface (representative punctum pointed by red arrowheads) at DIV14. Regions without GABAAR puncta on
dendritic surface are marked by white arrowheads. Surface GABAAR, wildtype, n=19:4 (# neurons:# mice); Arfgef1fs/+, n=23:7. Total GABAAR, wildtype,
n= 19:4; Arfgef1fs/+, n=23:7. All scale bars, 10 μm. C, At DIV14, synaptic GABAAR puncta (white arrowheads) on the dendritic surface are fewer on Arfgef1fs/+
dendrite. Wildtype, n= 19:4; Arfgef1fs/+, n=12:4. All scale bars, 10 μm. D, E, Graphs show quantiﬁcation of the dendritic surface GABAAR density and total
GABAAR density in dendrite. F, Graph shows the synaptic GABAAR density and total synapse density on dendritic surface. Density is deﬁned as punctum number per
dendritic length in μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Amplicon size: 495 bp.
Sec7 domain
Forward: 5′- GGA ATT GGC AGC TAC AGT ACA CAG -3′.
Reverse: 5′- CCT GTG GAC TGT GAA GGT CTG -3′.
Amplicon size: 505 bp.
Exon 29-31
Forward: 5′- GAC AAC ATG AAA TTG CCA GAA CAG C -3′.
Reverse: 5′- GAT ATC CAG GGT GCA GTT ACA CG -3′.
Amplicon size: 285 bp.
HSD4 domain
Forward: 5′- GCT GGA ACT CAT CCA GAC CAT C -3′.
Reverse: 5′- TGA GCT TTA AAC CTG CTG TCA CTG -3′.
Amplicon size: 524 bp.
Actin
Forward: 5′- ACG ATA TCG CTG CGC TGG -3′.
Reverse: 5′- GAG CAT CGT CGC CCG C -3′.
Amplicon size: 72 bp.
4.3. Antibodies
The following primary antibodies were used: Anti-Arfgef1 N-term-
inal epitope (ThermoFisher Scientiﬁc, PA5-54894; Santa Cruz, sc-
376790; sc-50391), anti-Arfgef1 C-terminal epitope (Bethyl, A300-
998A), anti-Arfgef2 C-terminal epitope (Sigma-Aldrich, MABS1246),
Anti-GABAA Receptor with epitope for extracellular domain of the β2,3
subunits (Millipore Sigma, MAB341), anti-synaptophysin
(ThermoFisher Scientiﬁc, PA1-1043), anti-lamp1 (DSHB, 1D4B), anti-
eea1 (R&D Systems, AF8047), anti-transferrin receptor (Abcam,
ab84036), anti-Rab11 (ThermoFisher Scientiﬁc, 71-5300), anti-Arf6
(ThermoFisher Scientiﬁc, PA1-093), anti-map2 (Millipore Sigma,
Ab5622), anti-ankG (Santa Cruz, sc-28561), anti-ß-tubulin
(Proteintech, 10094-1-AP and 66240-1-Ig), anti-GAPDH (Proteintech,
60004-1-Ig), anti-lamin B1 (Proteintech, 66095-1-lg). The following
secondary antibodies were used: Goat anti-mouse HRP-conjugated IgG
(Proteintech, SA00001-1), goat anti-rabbit HRP-conjugated IgG
(Proteintech, SA00001-2), Goat anti-mouse Alexa Fluor 488-conjugated
IgG (ThermoFisher Scientiﬁc, A11017), goat anti-rabbit Alexa Fluor
594-conjugated IgG (ThermoFisher Scientiﬁc, A11072), goat anti-rat
Alexa Fluor 594-conjugated IgG (ThermoFisher Scientiﬁc, A11007),
donkey anti-sheep NL557-conjugated IgG (R&D Systems, NL010).
4.4. Western blotting
Brain lysates were collected using the trichloroacetic acid pre-
cipitation method. Brieﬂy, the lysates were separated by SDS-PAGE and
transferred to Immobilon-PSQ PVDF Membrane (Millipore Sigma,
ISEQ00010). The membranes were incubated with primary antibodies
overnight at 4 °C, followed by incubation with the appropriate HRP-
Fig. 6. Distribution of intracellular vesicles colocalized with GABAAR in wildtype and Arfgef1fs/+ DIV14 neurons. A, B, C, D, E, Graphs show the density of GABAAR
colocalized with Arf6+, Rab11+, TrfR+ recycling endosomes, EEA1+ early endosomes and Lamp1+ lysosomes in cell body and dendrite. Arf6+ GABAAR+, wildtype,
n= 19:4 (# neurons:# mice); Arfgef1fs/+, n=23:7. Rab11+ GABAAR+, wildtype, n= 16:4; Arfgef1fs/+, n= 27:7; TrfR+ GABAAR+, wildtype, n= 15:4; Arfgef1fs/
+, n=18:3; EEA1+ GABAAR+, wildtype, n=21:6; Arfgef1fs/+, n= 19:5; Lamp1+ GABAAR+, wildtype, n= 18:6; Arfgef1fs/+, n=18:5. F & G, Graphs show the
density of Arf6+, Rab11+, TrfR+ and EEA1+ vesicles colocalized with Arfgef1 or Arfgef2 in dendrite. For each vesicle type plus Arfgef1 or Arfgef2 data set, wildtype,
n= 3:3; Arfgef1fs/+, n=3:3. H, The number of Lamp+ lysosomes and GABAAR-containing lysosomes increase in Arfgef1fs/+ neurons. All scale bars, 5 μm. Density is
shown in log scale.
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conjugated secondary antibody for 1 h at room temperature. Samples
were washed three times in PBS with 0.05% Tween-20 (PBST) after
each step. Signals were developed using Amersham ECL Western
Blotting Detection Reagent (GE Healthcare, RPN2106) and visualized
using western blot imaging system (Azure Biosystems, Azure C400).
4.5. Video-EEG
Mice of both sexes, aged 5 weeks and 8weeks were anesthetized
through intraperitoneal injection of 400mg/kg 2,2,2-Tribromoethanol
(Sigma Aldrich, T48402). Surgery was performed to drill four burr
holes. The ﬁrst two holes located 1mm anterior to bregma on both
sides. The third hole located 2mm posterior to bregma on the left side.
The fourth hole located over the cerebellum as reference. Four teﬂon-
coated silver wires soldered on a microconnector (Mouser electronics,
575-501101) were placed between dura mater and pia mater and a
dental cap was applied. Post-operative mice were given 5mg/kg car-
profen (Zoetis, Rimadyl injectable) subcutaneously and a recovery time
of 48 h before electroencephalography (EEG) recording. The recovered
mice were then connected to Natus Quantum programmable ampliﬁer
(Natus Neurology, 014160) for 24 h over one day-night cycle. The mice
activity was video-recorded simultaneously using a night-vision-en-
abled Sony IPELA EP500 camera. Diﬀerential ampliﬁcation recordings
were recorded pair-wise between the three electrodes and a referential
electrode, resulted in a montage of 6 channels for each mouse. The EEG
data was analyzed using Natus Database v8.5.1.
4.6. Seizure susceptibility tests
Electroconvulsive threshold testing was performed in mice
7–10weeks of age as described previously with minor modiﬁcation
(Frankel et al., 2001)s (Frankel et al., 2001). Brieﬂy, a drop of a topical
anesthetic (0.5% tetracaine in 0.9% NaCl) was placed on each eye of a
restrained mouse, and current was applied using silver transcorneal
electrodes connected to an electroconvulsive stimulator (Ugo Basile
model 7801) using the following parameters: 299 Hz frequency 1.6ms
pulse width, 0.2 s pulse duration, variable current. Mice were tested
approximately daily in 0.5mA increments until the minimal clonic
forebrain seizure endpoint was reached. For analysis the mean in-
tegrated root mean square (iRMS) current is reported for each geno-
type-sex group.
Chemical seizure susceptibility was performed using subcutaneous
injection of mice between 9 and 10weeks of age using pentylenete-
trazol (PTZ), a GABAA receptor antagonist. Mice were observed for
30min and incidence of and latency to the ﬁrst tonic-clonic seizure
endpoint was recorded. The PTZ dose of 40mg/kg was predetermined
to be near the threshold for the tonic-clonic seizure endpoint in C57BL/
6NJ mice of this age.
The Wilcoxon non-parametric rank-sum test with 1000 permuta-
tions was used in R to determine permutation p-values for elecro-
convulsive threshold and for latency to PTZ-induced tonic-clonic sei-
zure.
4.7. Developmental milestones and ultrasonic vocalization
All pups from the same litter were kept with respective mother
throughout the experimental period. They were numbered with tattoo
on the soles at PND2 and evaluated for neurological reﬂexes on PND 3,
5, 7, 9 and 11. Each subject was tested at the same three-hour time
window of a day. The pups were weighted each day during the test. For
righting reﬂex test, the pup was placed on its back on a ﬂat and hard
surface. The time a pup took to right itself on all four paws was re-
corded. For negative geotaxis test, the pup was placed with head facing
downward on a 20× 20 cm ﬂat wire mesh screen slanted at 45° angle.
The time a pup took to turn around and face the angle of 90° and 180°
from the starting downward direction was recorded. For vertical screen
grasping test, the pups were placed on a 20× 20 cm ﬂat wire mesh
standing vertically at an angle of 90° to a ﬂat surface. The time a pup
was able to maintain itself on the mesh wire was recorded. All the times
were recorded using a stopwatch for a maximum of 30 s (s). All test
were carried out under room temperature. The pups were returned to
the mother immediately after the tests.
Ultrasonic vocalization from a pup being isolated from its mother
and littermates was recorded on PND 4, 6, 8 and 10. Brieﬂy, a random
pup was removed gently from its nest into an isolation container ﬁlled
with clean bedding. The container was then placed into a sound at-
tenuating chamber equipped with an UltraSoundGate Condenser
Microphone CM 16 (Avisoft Bioacoustics, 40011). The microphone
connected to an UltraSoundGate 116 USB audio device (Avisoft
Bioacoustics) was linked to a computer installed with Avisoft RECOR-
DER v2.97, where the acoustic data was recorded at a sampling rate of
250,000 Hz in 16 bit format. The software was programmed to ﬁltered
away acoustic frequency lower than 15 kHz to reduce background noise
interference. Each pup was recorded for 3min, weighted, and then
returned to nest with mother immediately. The number of calls emitted
by the pups was counted by an independent operator blinded from the
genotypes. The Wilcoxon non-parametric rank-sum test with 1000
permutations was used in R to determine permutation p-values.
4.8. Hematoxylin and eosin staining
Mice of respective ages were perfused. The brains were carefully
extracted and cut along the lambda-bregma points. Pieces of brains
were ﬁxed in 4% (w/v) paraformaldehyde (PFA) in 0.1 M phosphate
buﬀer (PB) at pH 7.4 overnight at 4 °C. After serial dehydration steps,
the brains were embedded in paraﬃn (Sigma, P3808). The brains were
sectioned at 5 μm thickness using Leica RM2125 microtome. Every
tenth section were collected on a glass slide (Matsunami Glass,
SUMGP14) and subjected to HE staining. Brieﬂy, the slices were rehy-
drated and stained with hematoxylin then counterstained with eosin.
These slices were subsequently dehydrated using ethanol and xylene
and mounted with coverslip using Permount (Fisher Chemical,
SP15–500). Histological images were acquired using a Nikon Eclispse
E800M light microscope and NIS-elements v4.51. Images were merged
using automated function in Photoshop CC 2015.
4.9. Ex vivo single neuron diolistic labeling and spine analysis
The postnatal day (PND) 14 brains were collected and ﬁxed as de-
scribed above. These brains were transferred into fresh 2% PFA in
0.1 M PB at pH 7.4 and stored at 4 °C for up to two months before use.
The brains were embedded in 4% agarose and shot with a gene gun
(Biorad, 1652451) loaded with homemade bullets consisting tungsten
microbeads (Biorad, 1652267) coated with DiI (Invitrogen, D282) at 80
PSI. After gentle washing, the brains were immersed in fresh 2% PFA in
0.1 M PB at pH 7.4 and stored in a dark moisten chamber for 3 days at
room temperature to allow dye diﬀusion. Finally, the brains were sliced
at 300uM using a vibrotome (Leica, VT1200) and mounted with cov-
erslip using glycerol. Z-stacks images were acquired immediately using
Zeiss LSM-800 confocal microscope and Zen v2.3. The quantiﬁcation
and morphological analysis of spines were done using NeuronStudio
v0.9.92. In agreement with literature, the spine shapes were categor-
ized as ﬁlopodia, thin, mushroom and stubby (Qiao et al., 2016). Spines
with a neck are classiﬁed as thin or mushroom based on the head
diameter. Spines longer than 3mm were classiﬁed as ﬁlopodia. Spines
without a neck are classiﬁed as stubby.
4.10. Primary hippocampal neuron culture
Primary hippocampal neurons were collected according to Fath's
method with little modiﬁcation (Fath et al., 2009). Brieﬂy, hippocampi
were dissected from embryonic day (E) 17.5 embryos, dissociated
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through trituration with the aid of papain (Worthington, LK003178)
pre-incubation. A total of 1× 105 cells was plated in 35mm culture
dish containing acid-treated coverslips coated with poly-D-lysine
(Sigma-Aldrich, P7886) and laminin (Gibco, 23017015). The primary
hippocampal neurons were kept in culture medium containing Neuro-
basal-A medium (Gibco, 10888022) supplemented with B27 (Gibco,
17504044) and Glutamax (Gibco, 35050061). Cytosine β-D-arabino-
furanoside (Sigma-Aldrich, C1768) was added once to a ﬁnal con-
centration of 3 μM on the next day after 50% medium change. The
cultures were maintained at 37 °C with 5% CO2 in a humidiﬁed in-
cubator. Every three days, 50% expensed medium were replaced with
fresh culture medium.
4.11. Immunoﬂuorescence
DIV14 neurons were ﬁxed for 10min at 4 °C with 4% (w/v) PFA in
0.1 M PB at pH 7.4. The ﬁxed neurons were incubated in blocking buﬀer
containing 5% goat serum (Gibco, 16210064) and 0.1% saponin
(Sigma-Aldrich, 47036) in PBS pH 7.4 (Gibco, 10010031) at room
temperature for 30min. Blocked neurons were subsequently incubated
with primary antibodies in blocking buﬀer at 4 °C overnight followed
by incubation with appropriate secondary antibodies and DAPI in
blocking buﬀer at room temperature for 2 h. Samples were washed
three times in PBS after each step. The stained neurons on coverslips
were mounted on glass slides using Fluoromount-G (Southern Biotech,
0100-01) and sealed with nail polish after drying at room temperature
overnight. Z-stacks images were acquired using Zeiss LSM-800 confocal
microscope and Zen v2.3. The quantiﬁcation and analysis of labeled
vesicle and GABAAR puncta were done using Imaris v9.2.1 software.
Due to the limitation of the point spread function (PSF) for tiny objects
in confocal microscopy, colocalization is quantiﬁed using an object-
based method (Dunn et al., 2011). Brieﬂy, vesicle and GABAAR puncta
stained with antibodies in cell body or dendrite are recognized and
segmented in diﬀerent channels using Imaris v9.2.1. If a punctum in
green channel and a punctum in red channel localize within 1 μm
proximity (center to center) the signal pair will be counted as coloca-
lized. There were no signiﬁcant diﬀerences found in the dendrite length
and the cell body area where the data were collected. Therefore, the
number of puncta in dendrite was normalized using dendrite length
(μm) and the number of puncta in cell body was normalized using cell
body area (μm2). The normalized numbers were presented as density
(in dendrite, vesicle number per μm; in cell body, vesicle number per
μm2).
For statistical analysis of puncta counts, a log-Poisson mixed model
was run using the lme4 package in R (www.R-project.org), with cell
body area or dendrite length as a respective covariate and a random
eﬀects term included to correct for signiﬁcant overdispersion in the
count data. To determine whether endosome ratios diﬀered between
mutant genotype and wildtype, genotype x vesicle type interaction
terms were included in a similar model which also included a ﬁxed term
for the individual biological from which ratios examined. Statistical
comparisons in this study were considered signiﬁcant if the p-value
is< 0.05.
4.12. Single cell patch-clamp recordings
To assess synaptic activity, electrophysiological recordings were
carried out from dissociated hippocampal neurons plated at a density of
50,000 cells on 15mm diameter glass coverslips and cultured for
13–15 days. Recordings were made in voltage clamp whole-cell con-
ﬁguration using a Multiclamp 700B ampliﬁer and a Digidata 1550 di-
gital-to-analogue converter (both from Molecular Devices) at a 10 kHz
sample frequency. Patch pipettes were fabricated with a P-97 pipette
puller (Sutter Instruments) using 1.5 mm outer diameter, 1.28mm
inner diameter ﬁlamented capillary glass (World Precision
Instruments). The external recording solution contained (in mM): NaCl
145, KCl 5, HEPES 10, Glucose 10, CaCl2 2, MgCl2 2, 0.001 te-
trodotoxin, pH 7.3 with NaOH, and osmolality adjusted to 325mOsm
using sucrose. A cesium-based pipette solution contained (in mM): ce-
sium methanesulfonate 130, sodium methanesulfonate 10, EGTA 10,
CaCl2 1, HEPES 10, TEA-Cl 10, MgATP 5, Na2GTP 0.5, QX-314 5, pH 7.2
with CsOH, adjusted to 290mOsm with sucrose. Pipettes had ﬁnal re-
sistance of approximately 5 ΜΩ when ﬁlled with internal solution.
Uncompensated series resistance was<15ΜΩ. Series resistance and
membrane capacitance were electrically compensated to approximately
70%. Miniature excitatory postsynaptic currents (mEPSCs) and minia-
ture inhibitory postsynaptic currents (mIPSCs), were recorded from the
same cell by holding the cells at −60 and 0mV, respectively.
Recordings were acquired for a period of 5min. All recordings were
carried out at room temperature (21–23 °C). Miniature events were
detected oﬄine with Clampﬁt 12.7 (Molecular Devices) using the
template matching function and a minimum threshold of 5 pA. Each
event was manually inspected to determine inclusion or rejection in
analysis. Further analysis was carried out using R (www.R-project.org).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2019.104632.
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